Daniel Faga, President, CEO at ANAPTYSBIO, INC (ANAB), sold 35,258 shares at $56.61 ($2.2M) on 2026-03-27, disclosed to the SEC on 2026-03-27.
Open-market sale of $2.2M ANAB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.61 | 510 | $29K | 1.3% |
| 2 | $56.61 | 510 | $29K | 1.3% |
| 3 | $57.91 | 2,570 | $149K | 6.9% |
| 4 | $57.91 | 2,570 | $149K | 6.9% |
| 5 | $58.62 | 3,662 | $215K | 9.9% |
| 6 | $58.62 | 3,662 |
| $215K |
| 9.9% |
| 7 | $59.62 | 490 | $29K | 1.3% |
| 8 | $59.62 | 490 | $29K | 1.3% |
| 9 | $60.63 | 550 | $33K | 1.5% |
| 10 | $60.63 | 550 | $33K | 1.5% |
| 11 | $62.15 | 1,012 | $63K | 2.9% |
| 12 | $62.15 | 1,012 | $63K | 2.9% |
| 13 | $63.35 | 2,592 | $164K | 7.6% |
| 14 | $63.35 | 2,592 | $164K | 7.6% |
| 15 | $64.19 | 3,155 | $203K | 9.3% |
| 16 | $64.19 | 3,155 | $203K | 9.3% |
| 17 | $65.20 | 3,038 | $198K | 9.1% |
| 18 | $65.20 | 3,038 | $198K | 9.1% |
| 19 | $65.99 | 100 | $7K | 0.3% |
| Total | $61.60 avg | 35,258 | $2.2M | 100% |
| Filing → |
| ANAB | SELL | 2026-01-06 | $662K | — | Filing → |
| ANAB | SELL | 2024-03-26 | $6.8M | — | Filing → |
| ANAB | SELL | 2024-01-09 | $299K | — | Filing → |